Cancer
A recent study published in Scientific Reports has identified several predictive factors for unplanned acute care (UAC) in outpatients receiving oral anticancer drugs. The research, conducted at the National Cancer Center Hospital East in Chiba, Japan, aimed to identify factors associated with increased risk of UAC, which can lead to
Cancer
Researchers at Guy's and St Thomas' NHS Foundation Trust and King's College London have explored the clinical potential of CAR T-cell-derived extracellular vesicles (CAR-EVs) as a revolutionary cancer treatment. CAR-EVs are nanovesicles released by CAR T cells, which can play a crucial role in intercellular
Cancer
Researchers at Guy's and St Thomas' NHS Foundation Trust and King's College London have explored the clinical potential of CAR T-cell-derived extracellular vesicles (CAR-EVs) as a revolutionary cancer treatment. CAR-EVs are nanovesicles released by CAR T cells, which can play a crucial role in intercellular
Cancer
Researchers at Guangzhou University of Chinese Medicine have made a significant discovery in the field of cancer immunotherapy. A new customized immunomodulator, developed by the team, has been shown to comprehensively reinforce the anti-tumor immunological cascade. This breakthrough has the potential to enhance the efficacy of immunotherapy for cold tumors,
Cancer
Researchers have discovered that tumor necrosis factor (TNF) plays a critical role in the development of colorectal cancer (CRC) through cellular reprogramming in intestinal epithelial cells. According to a new report published in Cell Communication and Signaling, prolonged TNF exposure can trigger CRC progression by inducing the expression of doublecortin-like
Cancer treatment
Research has shed new light on the potential of metformin, a medication commonly used to treat diabetes, in combating bladder cancer. A study published in BMC Cancer found that metformin can suppress bladder cancer cell proliferation and prolong survival in an orthotopic mouse model. The study's findings suggest
T cells
Researchers at Guy's and St Thomas' NHS Foundation Trust and King's College London have explored the clinical potential of CAR T-cell-derived extracellular vesicles (CAR-EVs) as a revolutionary cancer treatment. CAR-EVs are nanovesicles released by CAR T cells, which can play a crucial role in intercellular
Antineoplastic agents
A new analysis conducted by Komodo Health and the Tigerlily Foundation, a national breast cancer patient advocacy organization, reveals significant progress in the adoption of antibody-drug conjugate (ADC) treatment in metastatic breast cancer. The study confirms growing clinical acceptance of this innovative therapy but also highlights persistent inequities in access
Cancer treatment
A new analysis conducted by Komodo Health and the Tigerlily Foundation, a national breast cancer patient advocacy organization, reveals significant progress in the adoption of antibody-drug conjugate (ADC) treatment in metastatic breast cancer. The study confirms growing clinical acceptance of this innovative therapy but also highlights persistent inequities in access
Cancer
The construction of a new cancer care building at Tata Memorial Centre's Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) in Navi Mumbai has commenced, marking a significant milestone in the collaborative effort between ICICI Bank and TMC. Funded by ICICI Bank's CSR contribution
Cancer
Researchers at the University of Miami have published a review article in the journal Nanomedicine, highlighting the potential of magnetoelectric nanoparticles (MENPs) in cancer therapy. According to the study, MENPs, which generate electric fields in response to magnetic fields, can be used to target and destroy cancer cells without causing
Cancer
Researchers at the Shiraz University of Medical Sciences in Iran have explored the potential of targeted sonodynamic therapy in treating melanoma, one of the most aggressive forms of cancer. The study focused on the use of cerium oxide-bismuth oxide (CeBi) and folic acid-functionalized cerium oxide-bismuth oxide (FCeBi) nanohybrids, particularly in
